Philip Pancari, MD
Hematology · Orlando, FLNPI 1285953158
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $58,985 of the $69,696 with a category attached, or 84.6%. Sanofi-aventis U.S. LLC accounts for 96.3% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $67,996, more than ten times the $95 reported in 2019. Among hematology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $783.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$67K
- Genmab U.S., Inc.$357
- Bristol Myers Squibb$309
- Daiichi Sankyo Inc.$306
- Amgen$287
- Incyte Corporation$243
- plus $1K from 18 others
Across 12 payments — averaging $8364.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$75K
- Otsuka Pharmaceutical Co., Ltd.$24K
- Incyte Corporation$2K
What the payments were for
- Speaking & faculty fees$58,98585%
- Travel & lodging$7,28910%
- Food & beverage$3,4095%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 32 | $67,147 |
| Genmab U.S., Inc. | 4 | $357 |
| Bristol Myers Squibb | 12 | $309 |
| Daiichi Sankyo Inc. | 5 | $306 |
| Amgen | 3 | $287 |
| Incyte Corporation | 4 | $243 |
| Gilead(2 entities) | 3 | $166 |
| Johnson & Johnson | 1 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $134 |
| Seagen Inc. | 2 | $132 |
| Tempus AI, Inc | 1 | $100 |
| Legend Biotech USA Inc. | 3 | $93 |
| Novartis | 3 | $61 |
| AbbVie | 2 | $54 |
| Bayer | 1 | $24 |
| Servier Pharmaceuticals LLC | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Pfizer | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Spectrum Pharmaceuticals Inc. | 1 | $16 |
| Verastem, Inc. | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
| Foundation Medicine, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$69,696 in reported general payments places this provider in the 90th percentile of 79 hematology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Orlando
- Juan VarelaOrlando$131K
- Arlene GayleOrlando$14K
- Kayla DesuzaOrlando$7K
- Daniel AnscherOrlando$2K
- Ayman MukhtarOrlando$761
- Phillip MannoOrlando$153
- Javier Pinilla-IbarzTampa$1.6M
- Rami KomrokjiTampa$855K
- Ahmed ZakariAltamonte Springs$383K
- Alex Mejia GarciaVero Beach$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.